← Back to Search

Platelet Rich Plasma

PRP/Saline for Male Pattern Baldness

Waitlist Available
Led By Jerry Shapiro, MD
Research Sponsored by Vancouver General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights


The investigators plan to conduct a clinical trial to assess the effects and safety of platelet rich plasma on androgenetic alopecia.

Eligible Conditions
  • Male Pattern Baldness


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The degree of hair regrowth based on the hair regrowth score (RGS) for each side of scalp.
Secondary outcome measures
Changes in hair count and caliber. Changes in hair count and caliber

Trial Design

1Treatment groups
Experimental Treatment
Group I: PRP/SalineExperimental Treatment1 Intervention
Same patient will be injected with PRP and normal saline. Each one will be inject on half head.
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 4

Find a Location

Who is running the clinical trial?

Vancouver General HospitalLead Sponsor
40 Previous Clinical Trials
19,595 Total Patients Enrolled
Jerry Shapiro, MDPrincipal InvestigatorProfessor
2 Previous Clinical Trials
120 Total Patients Enrolled
~2 spots leftby Jul 2025